Research graph
References from UKPDS and beyond: into the next millennium. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140-6736(98)07019-6
10.1016/s0140-6736(98)07019-6 · External reference
10.1016/s0140-6736(98)07037-8
10.1016/s0140-6736(98)07037-8 · External reference
10.1136/bmj.317.7160.703
10.1136/bmj.317.7160.703 · External reference
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39).
10.1136/bmj.317.7160.713 · 1998 · External reference
10.1016/s0140-6736(98)22937-0
10.1016/s0140-6736(98)22937-0 · External reference
10.1136/bmj.317.7160.691
10.1136/bmj.317.7160.691 · External reference
10.1136/bmj.317.7160.693
10.1136/bmj.317.7160.693 · External reference
10.1007/bf00400195
10.1007/bf00400195 · External reference
10.1016/0168-8227(95)01064-k
10.1016/0168-8227(95)01064-k · External reference
10.1007/bf00403296
10.1007/bf00403296 · External reference
Risk factors for coronary artery disease in non‐insulin‐dependent diabetes mellitus.
1998 · External reference
A study of the effects of hypoglycemic agents on vascular complications in patients with adult‐onset diabetes.
1970 · External reference
10.1046/j.1464-5491.1999.00068.x
10.1046/j.1464-5491.1999.00068.x · External reference
10.2337/diacare.20.6.925
10.2337/diacare.20.6.925 · External reference
10.2337/diacare.21.9.1389
10.2337/diacare.21.9.1389 · External reference
10.1046/j.1464-5491.1999.00017.x
10.1046/j.1464-5491.1999.00017.x · External reference
10.1016/s0140-6736(05)78489-0
10.1016/s0140-6736(05)78489-0 · External reference
10.2165/00002018-199921010-00002
10.2165/00002018-199921010-00002 · External reference
10.1136/bmj.317.7173.1644
10.1136/bmj.317.7173.1644 · External reference
10.1002/(sici)1096-9136(1998110)15:11<895::aid-dia751>3.0.co;2-z
10.1002/(sici)1096-9136(1998110)15:11<895::aid-dia751>3.0.co;2-z · External reference
Implications of the United Kingdom Prospective Diabetes Study.
1999 · External reference
